A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non‐small cell lung cancer

BACKGROUND: Although clinical trials have investigated the addition of pembrolizumab to chemotherapy for non‐small cell lung cancer, none have investigated the addition of chemotherapy to pembrolizumab. METHODS: We conducted a retrospective study of 71 NSCLC patients including 33 treated with pembro...

Descripción completa

Detalles Bibliográficos
Autores principales: Isono, Taisuke, Kagiyama, Naho, Shibata, Shun, Nakajima, Hitomi, Matsui, Yuma, Takano, Kenji, Nishida, Takashi, Hosoda, Chiaki, Kawate, Eriko, Kobayashi, Yoichi, Ishiguro, Takashi, Takaku, Yotaro, Kurashima, Kazuyoshi, Yanagisawa, Tsutomu, Takayanagi, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088931/
https://www.ncbi.nlm.nih.gov/pubmed/33710764
http://dx.doi.org/10.1111/1759-7714.13915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088931/
https://www.ncbi.nlm.nih.gov/pubmed/33710764
http://dx.doi.org/10.1111/1759-7714.13915

Ejemplares similares